Subcutaneous heparins
Thies, H.A.; Gins, R.; Kuder, E.
Die Medizinische Welt 27(46): 2240-2241
1976
ISSN/ISBN: 0025-8512 PMID: 1004164 Document Number: 108653
Document emailed within 1 workday
Related Documents
Delsart, D.; Chambefort, V.; Decousus, H. 2001: Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins La Revue du Praticien 51(13): 1489-1497Naimer, S.A.; Biton, A.; Topaz, M. 2006: The subcutaneous loop: a single suture technique for skin closure after superficial and subcutaneous surgery Journal of Drugs in Dermatology: Jdd 5(10): 966-968
Kanzato, N.; Suehara, M.; Mayumi, H.; Hirata, K.; Ohta, M.; Kuniyoshi, M.; Kuniyoshi, K. 2000: Tracheopulmonary-subcutaneous fistula associated with anaerobic subcutaneous abscess on mechanical ventilator support in a patient with Duchenne muscular dystrophy Rinsho Shinkeigaku 40(5): 490-493
Samama, M. 1986: The new heparins Presse Medicale 15(32): 1631-1635
Rosocha, S.; Schmitz-Huebner, U. 1994: Low-molecular heparins Deutsche Medizinische Wochenschrift 119(18): 678
Linda M. Hiebert 2002: Oral Heparins Clinical Laboratory 48(3-4): 111-116
Agnelli, G.; Cosmi, B. 1990: Low molecular weight heparins Medicina 10(1): 9-15
Drouet, L. 1993: Low molecular weight heparins Presse Medicale 22(40): 2002-2008
Ebell, M.H. 1994: Low molecular weight heparins for DVT Journal of Family Practice 39(5): 501-502
Fareed, J.; Hoppensteadt, D.; Jeske, W.; Clarizio, R.; Walenga, J.M. 1998: Low molecular weight heparins: are they different? Canadian Journal of Cardiology 14 Suppl E: 28e-34e
Doutremepuich, C.; Puyal, C.; Lalanne, M.C.; Doutremepuich, F.; De Sèze, O. 1990: How to standardize low molecular weight heparins Annales de Biologie Clinique 48(4): 221-225
Pelouze, G.A. 1994: Fractionated heparins: LMWH or LMMH? Presse Medicale 23(26): 1223
De Lorenzo, F.; Dotsenko, O.; Kakkar, V.V. 2005: Low molecular weight heparins in cardiovascular medicine Minerva Cardioangiologica 53(6): 585-603
Horellou, M.H.; Samama, M. 1991: Low molecular weight heparins in everyday practice Journal des Maladies Vasculaires 16(2): 179-183
Vignes, S.; Meyer, G.; Marjanovic, Z.; Farge-Bancel, D. 1997: Current indications of low-molecular-weight heparins Annales de Medecine Interne 148(2): 154-162
González, P.; de la Sen, M.L.; Venegas, I.; Ramón, A.; Soriano, V.; Cueva, B.; Fernández, J. 2014: Immediate hypersensitivity to heparins: a cross-reactivity study Journal of Investigational Allergology and Clinical Immunology 24(5): 367-368
Samama, M.M.; Michaut-Paterno, F. 1991: Therapeutic indications of low molecular weight heparins Archives des Maladies du Coeur et des Vaisseaux 84(11 Suppl): 1733-1743
Gallimore, M.J.; Heller, W.; Fuhrer, G.; Wendel, H.; Klaffschenkel, R.; Hoffmeister, H.E. 1993: Contact activation, heparins and cardiopulmonary bypass Thrombosis and Haemostasis 69(1): 92-93
Hunt, D. 1998: Low-molecular-weight heparins in clinical practice Southern Medical Journal 91(1): 2-10
Mammen, E.F.; Arcelus, J.; Messmore, H.; Altman, R.; Nurmohamed, M.; Eldor, A. 1999: Clinical differentiation of low molecular weight heparins Seminars in Thrombosis and Hemostasis 25(Suppl 3): 135-144